BioCryst Pharmaceuticals Inc (NAS:BCRX)
$ 7.78 0.11 (1.43%) Market Cap: 1.61 Bil Enterprise Value: 2.09 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 78/100

BioCryst Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript

Mar 12, 2019 / 12:00PM GMT
Release Date Price: $8.32
Gena Wang
Barclays Bank PLC, Research Division - Research Analyst

Okay, it's my pleasure to introduce our first presenter, Jon Stonehouse from -- Chief Executive Officer of BioCryst, to give us a brief introduction, and then we will have a Q&A session.

Jon P. Stonehouse
BioCryst Pharmaceuticals, Inc. - CEO, President & Director

Good morning. Thank you, Gena, for the introduction and inviting us to your health care conference. With me today is our Chief Commercial Officer, Lynne Powell; and our Head of Investor Relations, John Bluth. And they'll be joining me in the Q&A session.

So as Gena said, I'll be giving just a quick overview of the company and our programs, but we'll spend the bulk of the time going through question-and-answer with Gena and, hopefully, questions from the audience.

So really exciting time to be a part of BioCryst, and there's a lot of activity going on. 2019 is a big year for us with some important milestones, and I look forward to sharing the progress we're making and our plans for the year. I'll be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot